· Education · Research Desk
A neutral read of 38 preclinical studies on the gastric pentadecapeptide, separating reproducible vascular findings from extrapolated claims.
This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.
For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.